Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Arbor Pharmaceuticals, a pharmaceutical company focused on pediatric medicine, has unveiled ZINOTIC ES for the treatment of Acute Otitis Externa (AOE). ZINOTIC ES, an extra strength formulation of original ZINOTIC, provides pain relief and skin protection for children suffering from AOE.
Subscribe to our email newsletter
AOE or “swimmer’s ear” is a common childhood infection of the ear canal characterised by intense pain and inflamed, damaged skin. AOE treatment should address three main goals including treating the infection, relieving the pain and restoring the integrity of the lining of the ear canal.
Jarrett Disbrow, President and CEO of Arbor Pharmaceuticals, said: “ZINOTIC has become an important AOE treatment option since its introduction, and new ZINOTIC ES will be a welcome addition to the ZINOTIC franchise as it further addresses the three AOE treatment goals with its enhanced, extra strength formulation.”